These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 34842191)

  • 1. Epileptic Seizures in Alzheimer's Disease: What Are the Implications of SANAD II?
    Larner AJ; Marson AG
    J Alzheimers Dis; 2022; 85(2):527-529. PubMed ID: 34842191
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The SANAD II study of the effectiveness and cost-effectiveness of levetiracetam, zonisamide, or lamotrigine for newly diagnosed focal epilepsy: an open-label, non-inferiority, multicentre, phase 4, randomised controlled trial.
    Marson A; Burnside G; Appleton R; Smith D; Leach JP; Sills G; Tudur-Smith C; Plumpton C; Hughes DA; Williamson P; Baker GA; Balabanova S; Taylor C; Brown R; Hindley D; Howell S; Maguire M; Mohanraj R; Smith PE;
    Lancet; 2021 Apr; 397(10282):1363-1374. PubMed ID: 33838757
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnosing epileptic seizures in patients with Alzheimer's disease and deciding on the appropriate treatment plan.
    Brigo F; Lattanzi S
    Expert Rev Neurother; 2024 Apr; 24(4):361-370. PubMed ID: 38426448
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The SANAD II study of the effectiveness and cost-effectiveness of valproate versus levetiracetam for newly diagnosed generalised and unclassifiable epilepsy: an open-label, non-inferiority, multicentre, phase 4, randomised controlled trial.
    Marson A; Burnside G; Appleton R; Smith D; Leach JP; Sills G; Tudur-Smith C; Plumpton C; Hughes DA; Williamson P; Baker GA; Balabanova S; Taylor C; Brown R; Hindley D; Howell S; Maguire M; Mohanraj R; Smith PE;
    Lancet; 2021 Apr; 397(10282):1375-1386. PubMed ID: 33838758
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Study protocol for a pragmatic randomised controlled trial comparing the effectiveness and cost-effectiveness of levetiracetam and zonisamide versus standard treatments for epilepsy: a comparison of standard and new antiepileptic drugs (SANAD-II).
    Balabanova S; Taylor C; Sills G; Burnside G; Plumpton C; Smith PEM; Appleton R; Leach JP; Johnson M; Baker G; Pirmohamed M; Hughes DA; Williamson PR; Tudur-Smith C; Marson AG
    BMJ Open; 2020 Aug; 10(8):e040635. PubMed ID: 32847927
    [TBL] [Abstract][Full Text] [Related]  

  • 6. From here to epilepsy: the risk of seizure in patients with Alzheimer's disease.
    Nicastro N; Assal F; Seeck M
    Epileptic Disord; 2016 Mar; 18(1):1-12. PubMed ID: 26907471
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of epilepsy for people with Alzheimer's disease.
    Liu J; Wang LN; Wu LY; Wang YP
    Cochrane Database Syst Rev; 2016 Nov; 11(11):CD011922. PubMed ID: 27805721
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of epilepsy in patients with Alzheimer's disease.
    Giorgi FS; Guida M; Vergallo A; Bonuccelli U; Zaccara G
    Expert Rev Neurother; 2017 Mar; 17(3):309-318. PubMed ID: 27687685
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacotherapeutic strategies for treating epilepsy in patients with Alzheimer's disease.
    Cretin B
    Expert Opin Pharmacother; 2018 Aug; 19(11):1201-1209. PubMed ID: 30009650
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epileptic seizures in Alzheimer's disease: another fine MESS?
    Larner AJ; Marson AG
    J Alzheimers Dis; 2011; 25(3):417-9. PubMed ID: 21441660
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A randomised controlled trial examining the longer-term outcomes of standard versus new antiepileptic drugs. The SANAD trial.
    Marson AG; Appleton R; Baker GA; Chadwick DW; Doughty J; Eaton B; Gamble C; Jacoby A; Shackley P; Smith DF; Tudur-Smith C; Vanoli A; Williamson PR
    Health Technol Assess; 2007 Oct; 11(37):iii-iv, ix-x, 1-134. PubMed ID: 17903391
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Levetiracetam, lamotrigine, and phenobarbital in patients with epileptic seizures and Alzheimer's disease.
    Cumbo E; Ligori LD
    Epilepsy Behav; 2010 Apr; 17(4):461-6. PubMed ID: 20188634
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epilepsy treatment in adults and adolescents: Expert opinion, 2016.
    Shih JJ; Whitlock JB; Chimato N; Vargas E; Karceski SC; Frank RD
    Epilepsy Behav; 2017 Apr; 69():186-222. PubMed ID: 28237319
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Choice of therapeutic anti-seizure medication in patients with brain tumour.
    Laghari AA; Ahmed SI; Qadeer N; Shamim MS
    J Pak Med Assoc; 2019 Mar; 69(3):442-444. PubMed ID: 30890845
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The SANAD study of effectiveness of valproate, lamotrigine, or topiramate for generalised and unclassifiable epilepsy: an unblinded randomised controlled trial.
    Marson AG; Al-Kharusi AM; Alwaidh M; Appleton R; Baker GA; Chadwick DW; Cramp C; Cockerell OC; Cooper PN; Doughty J; Eaton B; Gamble C; Goulding PJ; Howell SJ; Hughes A; Jackson M; Jacoby A; Kellett M; Lawson GR; Leach JP; Nicolaides P; Roberts R; Shackley P; Shen J; Smith DF; Smith PE; Smith CT; Vanoli A; Williamson PR;
    Lancet; 2007 Mar; 369(9566):1016-26. PubMed ID: 17382828
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative efficacy of antiepileptic drugs for patients with generalized epileptic seizures: systematic review and network meta-analyses.
    Campos MSA; Ayres LR; Morelo MRS; Carizio FAM; Pereira LRL
    Int J Clin Pharm; 2018 Jun; 40(3):589-598. PubMed ID: 29744790
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacological Medical Treatment of Epilepsy in Patients with Dementia: A Systematic Review.
    Musaeus CS; Nilsson C; Cooper C; Kramberger MG; Verdelho A; Stefanova E; Religa D; Waldemar G; Frederiksen KS
    Curr Alzheimer Res; 2021; 18(9):689-694. PubMed ID: 34825872
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of Juvenile Myoclonic Epilepsy in Patients of Child-Bearing Potential.
    Serafini A; Gerard E; Genton P; Crespel A; Gelisse P
    CNS Drugs; 2019 Mar; 33(3):195-208. PubMed ID: 30747367
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Summary of recommendations for the management of infantile seizures: Task Force Report for the ILAE Commission of Pediatrics.
    Wilmshurst JM; Gaillard WD; Vinayan KP; Tsuchida TN; Plouin P; Van Bogaert P; Carrizosa J; Elia M; Craiu D; Jovic NJ; Nordli D; Hirtz D; Wong V; Glauser T; Mizrahi EM; Cross JH
    Epilepsia; 2015 Aug; 56(8):1185-97. PubMed ID: 26122601
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The overlap between epilepsy and Alzheimer's disease and the consequences for treatment.
    Powell G; Ziso B; Larner AJ
    Expert Rev Neurother; 2019 Jul; 19(7):653-661. PubMed ID: 31238746
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.